1. Vulvovaginal Issues in Mature Women.
- Author
-
Marnach ML and Torgerson RR
- Subjects
- Administration, Intravaginal, Atrophy drug therapy, Dermatologic Agents administration & dosage, Dermatologic Agents therapeutic use, Diagnosis, Differential, Dyspareunia prevention & control, Estrogen Replacement Therapy methods, Estrogens therapeutic use, Female, Humans, Lichen Planus diagnosis, Lichen Planus drug therapy, Neurodermatitis diagnosis, Neurodermatitis drug therapy, Quality of Life, Sexual Dysfunction, Physiological drug therapy, Sexual Dysfunction, Physiological etiology, Skin Diseases drug therapy, Vaginal Creams, Foams, and Jellies administration & dosage, Vaginal Creams, Foams, and Jellies therapeutic use, Vulvar Diseases drug therapy, Vulvar Lichen Sclerosus diagnosis, Vulvar Lichen Sclerosus drug therapy, Dyspareunia etiology, Estrogens administration & dosage, Postmenopause physiology, Sexual Dysfunction, Physiological diagnosis, Skin Diseases diagnosis, Vulva pathology, Vulvar Diseases diagnosis, Women's Health
- Abstract
Mature women often present with symptomatic vulvovaginal atrophy and vulvar dermatoses, causing noncoital pain, dyspareunia, and sexual changes. Diagnosis of these conditions can be challenging, and long-term management is required to decrease morbidity and enhance quality of life. Vaginal estrogen therapies remain safe and effective for treating symptomatic vulvovaginal atrophy. A vulvar biopsy is easy to perform and generally well tolerated when indicated for the diagnosis of lichen simplex chronicus, lichen sclerosus, and lichen planus. Therapy with moderate- to high-potency corticosteroids is effective for these frequently debilitating conditions., (Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF